Wieseler J, Ellis AL, McFadden A, Brown K, Starnes C, Maier SF, et al
Not yet on a Sermorelin protocol?
Visceral fat is an independent risk factor for cardiovascular disease, type 2 diabetes, and metabolic syndrome, so reducing it produces broad metabolic benefits (Tchernof & Despres, 2013)
If you are currently prescribing any of these peptides through a compounding pharmacy, now is the time to confirm that your pharmacy is 503A-compliant and to understand what the absence of a formal Bulks List designation means for the current legality of those prescriptions
When GHK-Cu exposure shifts gene-expression patterns in aging cells partway back toward a younger profile, the expression pattern movesbut the cell does not suddenly turn back its clock